India has a lot of people with diabetes. This changes the market for diabetic products in India in a big way. There is a big market for products and services related to diabetes because a lot of people have it and their lives change all the time.
Asia's population is changing, with more middle-class people moving there and people getting older in general. This helps the diabetes market grow.
In the diabetes business, the state of India's health care system is a very important thing to talk about. People with diabetes want things and services that help them more when the cost of healthcare facilities, testing services, and treatment choices is high.
When the government fights diabetes and makes health rules better for everyone, it has an effect on the market. Indian laws about health care funds, public teaching programs, and ways to keep people from getting diabetes have an effect on the diabetes business.
Innovations in health care technology, especially those used to treat diabetes, are a big reason why the market is growing. New medical technologies, like meters that track glucose, systems that give insulin, and digital health solutions, have an effect on business.
One important thing that could change how much diabetes patients know and understand. People want better ways to avoid getting diabetes, find out early if they do have it, and get good care. This is what's moving the market for items and services connected to diabetes.
Diabetes changes the market because people from different cultures have different health habits and ideas. To get into the market and get people to accept new ways to handle diabetes, you need to know about and deal with the cultural gaps that present.
Prices and amounts of income are just two of the economic factors that affect the market. What changes the market are how much people can pay for diabetes care items and services and how many generic drugs are available at fair prices.
Drug firms, medical device businesses, and health care providers are competing in India's diabetes industry. Marketers constantly brainstorm fresh, innovative, and affordable concepts to keep ahead of the competition.
The area of diabetes is always getting better because new products are being made possible by the research and development that is being done. Companies that spend money on research and development can keep the market growing and adapt to the needs of their customers as they change.
In the diabetes market, partnerships between Indian businesses and health care groups from around the world have an impact. When these companies work together, they bring in foreign knowledge, new tools, and money to change the direction of the business.
Report Attribute/Metric | Details |
---|---|
Market Size Value In 2023 | USD 6.75 billion |
Growth Rate | 6.54% (2024-2032) |
The India diabetes market size was valued at USD 6.75 Billion in 2023 and is projected to grow from USD 6.86 Billion in 2024 to USD 11.46 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.54% during the forecast period (2024 - 2032). Diabetes is a chronic metabolic condition that results in high blood glucose levels, which seriously harms the heart, blood vessels, eyes, kidneys, and nerves. Drugs used to treat diabetes are known as diabetic therapies, which consist of oral diabetes medications and human insulin mimics.
The leading causes of diabetes mellitus in Indians are obesity, particularly central obesity, increased visceral fat brought on by physical inactivity, and diets high in calories, fat, and sugar. The most prevalent work culture that is still practised in the nation, which involves consuming fast food while engaging in little to no physical exercise and spending hours in one position while seated, is a major factor in the rapid rise in diabetes incidence among India's working-age population. Additionally, the rising number of diabetic people and its growing prevalence and expanding use of insulin-delivery and continuous glucose monitoring devices are propelling market expansion. In India, 77 million people were estimated to have diabetes in 2019, and by 2045, that number is expected to reach over 134 million. About 57% of these people are still undiagnosed. However, problems faced by poor individuals across India in managing diabetes care are major restraining factors for the market.
The said market segment has been segmented based on type which comprises Type 1, Type 2, and Gestational diabetes.
Based on tests, the market is segmented into Random blood sugar tests, Fasting blood sugar tests, Oral glucose tolerance tests, Initial glucose challenge tests and others.
Based on devices, it is segmented into Blood glucose monitoring devices, Diabetes management devices, and others.
Based on treatment, the market is segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery and Blood Sugar Treatment.
Considering the scenario of the Indian diabetes market, the western region is believed to be the largest market share holder for diabetes care. Moreover, the Eastern and Northern regions are also growing and the second-largest market for India's Diabetes treatment sector. On the other hand, the Southern Indian market is expected to grow at a significant rate in the Indian diabetes market during the forecasted period. The central region is likely to have limited but moderate growth in the said market segment.
India Diabetes Market Key Players Insights
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)